DIAGNOS Inc.
DGNOFOTCHealthcare● Active
$0.15
$-0.01(-3.41%)
Market Cap$15289633
P/E Ratio—
52W High$0.29
52W Low$0.13
DIAGNOS Inc. (DGNOF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DGNOF · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 25, 2026EPS Actual
-$0.01
Revenue
$0.00B
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 25, 2026
After Market Close
DGNOF reports quarterly as a OTC-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 20, 2026 | -$0.01 | — | — | — | $0.00B | — |
| ◌ Q2 FY2026 | Jun 9, 2026 | -$0.01 | — | — | — | $0.00B | — |
| ◌ Q2 FY2026 | Jun 4, 2026 | — | — | — | — | — | — |
| — Q1 FY2026 | Feb 25, 2026 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2025 | Nov 20, 2025 | — | -$0.01 | — | $0.00B | — | — |
| — Q3 FY2025 | Aug 20, 2025 | — | -$0.01 | — | $0.00B | — | — |
| ▼ Q2 FY2025 | May 28, 2025 | -$0.01 | -$0.01 | -43.9% | $0.00B | $0.00B | -85.3% |
| ▼ Q1 FY2025 | Feb 12, 2025 | -$0.01 | -$0.01 | -43.9% | $0.00B | $0.00B | -61.7% |
Q3 FY2026
Aug 20, 2026
EPS Actual
—
EPS Est.
-$0.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
Jun 9, 2026
EPS Actual
—
EPS Est.
-$0.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
Jun 4, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 25, 2026
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2025
Nov 20, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2025
Aug 20, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
May 28, 2025Miss
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
-43.9%
Revenue
$0.00B
Q1 FY2025
Feb 12, 2025Miss
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
-43.9%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2030 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q4 FY2029 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q3 FY2029 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q2 FY2029 | $-0.02 | $-0.02 | $-0.02 | 1 |
| Q1 FY2029 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q4 FY2028 | $-0.01 | $-0.01 | $-0.01 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2030 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Feb 25, 2026 | — | $0.20 | $0.20 | -1.67% |
| — Q4 FY2025 | Nov 20, 2025 | — | $0.22 | $0.21 | -4.05% |
| — Q3 FY2025 | Aug 20, 2025 | — | $0.19 | $0.18 | -1.73% |
| ▼ Q2 FY2025 | May 28, 2025 | -43.9% | $0.17 | $0.16 | -7.65% |
| ▼ Q1 FY2025 | Feb 12, 2025 | -43.9% | $0.23 | $0.22 | -2.70% |
| ▼ Q4 FY2024 | Nov 21, 2024 | -35.3% | $0.18 | $0.19 | +1.36% |
| ▼ Q2 FY2024 | Apr 11, 2024 | -7.7% | $0.22 | $0.20 | -7.17% |
| ▼ Q1 FY2024 | Feb 28, 2024 | -32.6% | $0.21 | $0.21 | +0.10% |
Q1 FY2026-1.67%
Report Date
Feb 25, 2026
EPS Beat/Miss
—
Price Before
$0.20
Price After
$0.20
Q4 FY2025-4.05%
Report Date
Nov 20, 2025
EPS Beat/Miss
—
Price Before
$0.22
Price After
$0.21
Q3 FY2025-1.73%
Report Date
Aug 20, 2025
EPS Beat/Miss
—
Price Before
$0.19
Price After
$0.18
Q2 FY2025-7.65%
Report Date
May 28, 2025
EPS Beat/Miss
-43.9%
Price Before
$0.17
Price After
$0.16
Q1 FY2025-2.70%
Report Date
Feb 12, 2025
EPS Beat/Miss
-43.9%
Price Before
$0.23
Price After
$0.22
Q4 FY2024+1.36%
Report Date
Nov 21, 2024
EPS Beat/Miss
-35.3%
Price Before
$0.18
Price After
$0.19
Q2 FY2024-7.17%
Report Date
Apr 11, 2024
EPS Beat/Miss
-7.7%
Price Before
$0.22
Price After
$0.20
Q1 FY2024+0.10%
Report Date
Feb 28, 2024
EPS Beat/Miss
-32.6%
Price Before
$0.21
Price After
$0.21
Avg Miss Reaction-3.21%
Beat Rate0 / 8 quarters
Largest Move-7.65% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DGNOF ends December
DIAGNOS Inc. (DGNOF) most recently reported earnings on February 25, 2026 for Q1 FY2026, posting EPS of $-0.01 (in line with the analyst consensus of —). The next DGNOF earnings date is expected around September 1, 2026.
Each quarter, investors track DGNOF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DGNOF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DGNOF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DGNOF earnings · 4 questionsDIAGNOS Inc.'s next earnings report is expected around September 1, 2026. DGNOF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DGNOF historically reports after market close (AMC).
DGNOF earnings datewhen is DGNOF earningsDGNOF next earnings datewhen does DGNOF report earningsDGNOF earnings calendar
▸ Source: FMP · DIAGNOS Inc. SEC filings · US GAAP · DIAGNOS Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026